Has Jonathan Seghorn received payments from drug or device companies?

Yes. Drug and device makers reported $2,787 in general payments to Jonathan Seghorn across 225 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Seghorn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Seghorn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Seghorn

Psychiatric/Mental Health · New Iberia, LANPI 1003146101

Payments from drug & device makers

$2,787in general payments, 2019–2025

Across 225 payments — averaging $12.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Corium, LLC$274
Alkermes, Inc.$255
Ironshore Pharmaceuticals Inc.$166
Welch Allyn$131
Teva Pharmaceuticals USA, Inc.$115
plus $609 from 12 others

What the payments were for

Food & beverage$2,65695%
Other$1315%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	112	$1,237
Corium, LLC	52	$274
Alkermes, Inc.	12	$255
Ironshore Pharmaceuticals Inc.	13	$166
Welch Allyn	1	$131
Teva Pharmaceuticals USA, Inc.	5	$115
E.r. Squibb & Sons, L.L.C.	4	$97
Johnson & Johnson	6	$93
Vanda Pharmaceuticals Inc.	2	$64
Axsome Therapeutics, Inc.	3	$63
Supernus Pharmaceuticals, Inc.	4	$62
Neurocrine Biosciences, Inc.	2	$57
Indivior Inc.	2	$44
Noven Therapeutics, LLC	2	$39
Otsuka America Pharmaceutical, Inc.	2	$39
Neos Therapeutics, LP	1	$22
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15
Global Blood Therapeutics, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NONE$131

How this compares

$2,787 in reported general payments places this provider in the 70th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	38	$90,845
Risperdal ConstaRisperidone Microspheres	26	$63,038
Mirtazapine	447	$5,982
Aripiprazole	216	$5,757
Oxcarbazepine	114	$5,593
Buspirone Hcl	304	$4,228
Paroxetine Hcl	279	$3,658
Amitriptyline Hcl	168	$3,574
Trazodone Hcl	307	$2,841
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	117	$2,674
Lisdexamfetamine Dimesylate	16	$2,620
Divalproex Sodium ErDivalproex Sodium	73	$2,299
Lurasidone Hcl	38	$2,217
Olanzapine	150	$2,038
Quetiapine Fumarate	180	$1,958

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta	$93	$153,88364 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in New Iberia

Amy LacoutureBaton Rouge$663K
Amanda EymardHouma$617K
Amber LittlefieldBroussard$225K
Timothy PellegrinHouma$210K
Melissa GuilbeauLafayette$122K
Kimberly ForcinelShreveport$92K
Sattaria DilksLake Charles$57K
Joe TaylorHammond$38K
Lecy AlbaradoScott$34K
Michelle DyerLake Charles$33K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →